Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 13.49x is 35% below its estimated 5-year average of 20.64x, near the low end of its estimated 5-year range (13.29x–34.79x).
As of 2026-09-11T17:05:19.324Z. 17.63% below its estimated 12-month average of 16.38x.
Calculation as of: 2026-09-11T17:05:19.324Z.
Quote observation: 2026-09-11T17:05:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 528d3ba9148e81a59322c16104731b7399dfc1101138210616e0d0efbf11ec7a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
13.49x
EV/EBITDA RATIO AVG TTM
16.38x
EV/EBITDA RATIO AVG 3Y
16.93x
EV/EBITDA RATIO AVG 5Y
20.64x
EV/EBITDA RATIO AVG 10Y
17.92x
EV/EBITDA RATIO AVG 15Y
15.51x
EV/EBITDA RATIO AVG 20Y
13.78x
CURRENT VS TTM AVG
-17.63%
CURRENT VS 3Y AVG
-20.30%
CURRENT VS 5Y AVG
-34.64%
CURRENT VS 10Y AVG
-24.74%
CURRENT VS 15Y AVG
-13.03%
CURRENT VS 20Y AVG
-2.14%
SECTOR MEDIAN · HEALTHCARE
15.94x
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
-15.37%
vs the sector median at left
AstraZeneca PLC
Market Cap
$246.96B
EV/EBITDA Ratio
13.49x
TTM Avg
16.38x
3Y Avg
16.93x
5Y Avg
20.64x
Market Cap
$227.35B
EV/EBITDA Ratio
25.32x
TTM Avg
22.06x
3Y Avg
21.66x
5Y Avg
20.94x
Market Cap
$178.53B
EV/EBITDA Ratio
N/A
TTM Avg
46.28x
3Y Avg
29.49x
5Y Avg
22.12x
Market Cap
$176.76B
EV/EBITDA Ratio
18.76x
TTM Avg
19.13x
3Y Avg
20.63x
5Y Avg
19.24x
Market Cap
$345.58B
EV/EBITDA Ratio
15.03x
TTM Avg
13.85x
3Y Avg
13.74x
5Y Avg
15.19x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $246.96B | 13.49x | 16.38x | 16.93x | 20.64x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $227.35B | 25.32x | 22.06x | 21.66x | 20.94x |
| Amgen Inc. (AMGN)vs › | $204.76B | N/A | 15.41x | 16.31x | 15.14x |
| Novo Nordisk A/S (NVO)vs › | $190.61B | 7.83x | 9.45x | 20.10x | 22.32x |
| Gilead Sciences, Inc. (GILD)vs › | $178.53B | N/A | 46.28x | 29.49x | 22.12x |
| Abbott Laboratories (ABT)vs › | $176.76B | 18.76x | 19.13x | 20.63x | 19.24x |
| Roche Holding AG (RHHBY)vs › | $336.64B | N/A | N/A | N/A | N/A |
| Pfizer Inc. (PFE)vs › | $157.05B | 10.11x | 9.20x | 13.58x | 11.95x |
| UnitedHealth Group Incorporated (UNH)vs › | $345.58B | 15.03x | 13.85x | 13.74x | 15.19x |
| Danaher Corporation (DHR)vs › | $141.50B | 22.66x | 21.35x | 23.29x | 21.62x |
At 13.5, EV/EBITDA is near its estimated 20-year median — higher than 45% of readings in its estimated 20-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 20-year low
3.6
median
15.1
estimated 20-year high
34.8
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-09-10 | 13.60x |
| 2026-09-09 | 13.39x |
| 2026-09-08 | 13.63x |
| 2026-09-04 | 13.83x |
| 2026-09-03 | 13.99x |
| 2026-09-02 | 13.75x |
| 2026-09-01 | 13.81x |
| 2026-08-31 | 13.79x |
| 2026-08-28 | 13.83x |
| 2026-08-27 | 13.97x |
| 2026-08-26 | 14.10x |
| 2026-08-25 | 14.37x |
| 2026-08-24 | 14.14x |
| 2026-08-21 | 14.08x |
| 2026-08-20 | 13.97x |
| 2026-08-19 | 14.00x |
| 2026-08-18 | 13.63x |
| 2026-08-17 | 13.38x |
| 2026-08-14 | 13.35x |
| 2026-08-13 | 13.41x |
| 2026-08-12 | 13.51x |
| 2026-08-11 | 13.53x |
| 2026-08-10 | 13.77x |
| 2026-08-07 | 13.73x |
| 2026-08-06 | 13.71x |
| 2026-08-05 | 13.74x |
| 2026-08-04 | 13.29x |
| 2026-08-03 | 13.47x |
| 2026-07-31 | 14.36x |
| 2026-07-30 | 14.49x |
| 2026-07-29 | 14.64x |
| 2026-07-28 | 14.58x |
| 2026-07-27 | 14.46x |
| 2026-07-24 | 14.43x |
| 2026-07-23 | 14.36x |
| 2026-07-22 | 14.47x |
| 2026-07-21 | 14.44x |
| 2026-07-20 | 14.07x |
| 2026-07-17 | 14.41x |
| 2026-07-16 | 14.44x |
| 2026-07-15 | 14.37x |
| 2026-07-14 | 14.07x |
| 2026-07-13 | 14.45x |
| 2026-07-10 | 14.62x |
| 2026-07-09 | 15.15x |
| 2026-07-08 | 15.99x |
| 2026-07-07 | 16.29x |
| 2026-07-06 | 16.06x |
| 2026-07-02 | 16.44x |
| 2026-07-01 | 15.57x |
| 2026-06-30 | 16.01x |
| 2026-06-29 | 16.12x |
| 2026-06-26 | 15.92x |
| 2026-06-25 | 15.71x |
| 2026-06-24 | 15.50x |
| 2026-06-23 | 15.35x |
| 2026-06-22 | 14.99x |
| 2026-06-18 | 14.87x |
| 2026-06-17 | 15.10x |
| 2026-06-16 | 15.17x |
| 2026-06-15 | 15.06x |
| 2026-06-12 | 15.17x |
| 2026-06-11 | 15.44x |
| 2026-06-10 | 15.19x |
| 2026-06-09 | 15.53x |
| 2026-06-08 | 15.39x |
| 2026-06-05 | 15.73x |
| 2026-06-04 | 15.41x |
| 2026-06-03 | 14.98x |
| 2026-06-02 | 15.07x |
| 2026-06-01 | 15.25x |
| 2026-05-29 | 15.71x |
| 2026-05-28 | 15.68x |
| 2026-05-27 | 15.71x |
| 2026-05-26 | 15.83x |
| 2026-05-22 | 15.81x |
| 2026-05-21 | 16.02x |
| 2026-05-20 | 15.85x |
| 2026-05-19 | 15.63x |
| 2026-05-18 | 15.57x |
| 2026-05-15 | 15.39x |
| 2026-05-14 | 15.65x |
| 2026-05-13 | 15.87x |
| 2026-05-12 | 15.62x |
| 2026-05-11 | 15.41x |
| 2026-05-08 | 15.49x |
| 2026-05-07 | 15.46x |
| 2026-05-06 | 15.65x |
| 2026-05-05 | 15.36x |
| 2026-05-04 | 15.54x |
| 2026-05-01 | 15.64x |
| 2026-04-30 | 15.84x |
| 2026-04-29 | 16.09x |
| 2026-04-28 | 16.20x |
| 2026-04-27 | 16.27x |
| 2026-04-24 | 16.45x |
| 2026-04-23 | 16.65x |
| 2026-04-22 | 16.86x |
| 2026-04-21 | 16.93x |
| 2026-04-20 | 17.33x |
| 2026-04-17 | 17.66x |
| 2026-04-16 | 17.31x |
| 2026-04-15 | 17.37x |
| 2026-04-14 | 17.62x |
| 2026-04-13 | 17.45x |
| 2026-04-10 | 17.60x |
| 2026-04-09 | 17.67x |
| 2026-04-08 | 17.61x |
| 2026-04-07 | 17.34x |
| 2026-04-06 | 17.50x |
| 2026-04-02 | 17.55x |
| 2026-04-01 | 17.33x |
| 2026-03-31 | 17.05x |
| 2026-03-30 | 16.78x |
| 2026-03-27 | 16.34x |
| 2026-03-26 | 15.94x |
| 2026-03-25 | 16.24x |
| 2026-03-24 | 16.13x |
| 2026-03-23 | 15.99x |
| 2026-03-20 | 15.96x |
| 2026-03-19 | 16.38x |
| 2026-03-18 | 16.34x |
| 2026-03-17 | 16.57x |
| 2026-03-16 | 16.63x |
| 2026-03-13 | 16.46x |
| 2026-03-12 | 16.67x |
| 2026-03-11 | 16.74x |
| 2026-03-10 | 16.87x |
| 2026-03-09 | 16.87x |
| 2026-03-06 | 16.81x |
| 2026-03-05 | 17.07x |
| 2026-03-04 | 17.39x |
| 2026-03-03 | 17.41x |
| 2026-03-02 | 17.57x |
| 2026-02-27 | 17.95x |
| 2026-02-26 | 17.59x |
| 2026-02-25 | 17.74x |
| 2026-02-24 | 19.57x |
| 2026-02-23 | 19.42x |
| 2026-02-20 | 19.35x |
| 2026-02-19 | 19.74x |
| 2026-02-18 | 19.75x |
| 2026-02-17 | 19.82x |
| 2026-02-13 | 19.47x |
| 2026-02-12 | 19.38x |
| 2026-02-11 | 19.40x |
| 2026-02-10 | 18.38x |
| 2026-02-09 | 17.93x |
| 2026-02-06 | 18.37x |
| 2026-02-05 | 17.85x |
| 2026-02-04 | 17.88x |
| 2026-02-03 | 17.60x |
| 2026-02-02 | 17.96x |
| 2026-01-30 | 17.85x |
| 2026-01-29 | 17.50x |
| 2026-01-28 | 17.91x |
| 2026-01-27 | 17.93x |
| 2026-01-26 | 17.14x |
| 2026-01-23 | 17.00x |
| 2026-01-22 | 17.18x |
| 2026-01-21 | 16.78x |
| 2026-01-20 | 17.51x |
| 2026-01-16 | 18.20x |
| 2026-01-15 | 18.00x |
| 2026-01-14 | 18.12x |
| 2026-01-13 | 17.99x |
| 2026-01-12 | 17.71x |
| 2026-01-09 | 18.19x |
| 2026-01-08 | 17.97x |
| 2026-01-07 | 18.17x |
| 2026-01-06 | 18.15x |
| 2026-01-05 | 17.14x |
| 2026-01-02 | 17.46x |
| 2025-12-31 | 16.83x |
| 2025-12-30 | 17.30x |
| 2025-12-29 | 17.85x |
| 2025-12-26 | 17.34x |
| 2025-12-24 | 17.79x |
| 2025-12-23 | 17.49x |
| 2025-12-22 | 17.29x |
| 2025-12-19 | 17.33x |
| 2025-12-18 | 17.27x |
| 2025-12-17 | 17.64x |
| 2025-12-16 | 17.46x |
| 2025-12-15 | 17.56x |
| 2025-12-12 | 17.19x |
| 2025-12-11 | 17.27x |
| 2025-12-10 | 17.39x |
| 2025-12-09 | 17.14x |
| 2025-12-08 | 17.31x |
| 2025-12-05 | 17.18x |
| 2025-12-04 | 17.23x |
| 2025-12-03 | 17.51x |
| 2025-12-02 | 17.14x |
| 2025-12-01 | 17.25x |
| 2025-11-28 | 17.55x |
| 2025-11-26 | 17.97x |
| 2025-11-25 | 17.90x |
| 2025-11-24 | 17.46x |
| 2025-11-21 | 17.45x |
| 2025-11-20 | 17.03x |
| 2025-11-19 | 17.21x |
| 2025-11-18 | 16.80x |
| 2025-11-17 | 16.81x |
| 2025-11-14 | 16.77x |
| 2025-11-13 | 17.00x |
| 2025-11-12 | 16.84x |
| 2025-11-11 | 16.80x |
| 2025-11-10 | 16.77x |
| 2025-11-07 | 16.01x |
| 2025-11-06 | 17.50x |
| 2025-11-05 | 16.87x |
| 2025-11-04 | 17.15x |
| 2025-11-03 | 16.83x |
| 2025-10-31 | 17.10x |
| 2025-10-30 | 17.09x |
| 2025-10-29 | 17.00x |
| 2025-10-28 | 17.18x |
| 2025-10-27 | 17.03x |
| 2025-10-24 | 17.01x |
| 2025-10-23 | 17.43x |
| 2025-10-22 | 17.30x |
| 2025-10-21 | 17.43x |
| 2025-10-20 | 17.31x |
| 2025-10-17 | 17.68x |
| 2025-10-16 | 17.51x |
| 2025-10-15 | 17.41x |
| 2025-10-14 | 17.51x |
| 2025-10-13 | 17.50x |
| 2025-10-10 | 17.53x |
| 2025-10-09 | 17.58x |
| 2025-10-08 | 17.79x |
| 2025-10-07 | 17.60x |
| 2025-10-06 | 17.81x |
| 2025-10-03 | 17.64x |
| 2025-10-02 | 17.09x |
| 2025-10-01 | 16.89x |
| 2025-09-30 | 15.66x |
| 2025-09-29 | 15.34x |
| 2025-09-26 | 15.35x |
| 2025-09-25 | 15.68x |
| 2025-09-24 | 15.62x |
| 2025-09-23 | 15.78x |
| 2025-09-22 | 16.35x |
| 2025-09-19 | 16.12x |
| 2025-09-18 | 16.03x |
| 2025-09-17 | 16.28x |
| 2025-09-16 | 15.99x |
| 2025-09-15 | 16.14x |
| 2025-09-12 | 16.61x |
| 2025-09-11 | 16.84x |
| 2025-09-10 | 16.67x |
| 2025-09-09 | 16.70x |
| 2025-09-08 | 16.95x |
| 2025-09-05 | 17.08x |
| 2025-09-04 | 16.84x |
| 2025-09-03 | 16.86x |
| 2025-09-02 | 16.71x |
| 2025-08-29 | 16.76x |
| 2025-08-28 | 16.48x |
Showing the most recent 260 of 3,702 data points. The chart above shows the full history.
